Particular vulnerability of rat mesencephalic dopaminergic neurons to tetrahydrobiopterin: Relevance to Parkinson's disease

Neurobiology of Disease

Volumn 25, Issue 1, 2007, Pages 112-120

  Lee, So Yeon ^a   Moon, Younghye ^a   Hee Choi, Dong ^a   Jin Choi, Hyun ^a   Hwang, Onyou ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Apoptosis; Dopamine; Oxidative stress; Parkinson's disease; Rat primary mesencephalic neuronal culture; Tetrahydrobiopterin

Indexed keywords

ANTIOXIDANT; CASPASE 3; CYTOCHROME C; DOPAMINE; NEUROTRANSMITTER; PROTEIN; TETRAHYDROBIOPTERIN; UBIQUITIN;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DOPAMINE METABOLISM; DOPAMINERGIC NERVE CELL; EMBRYO; FEMALE; IMMUNOREACTIVITY; MEMBRANE POTENTIAL; MICROGLIA; MITOCHONDRIAL MEMBRANE; NERVE CELL LESION; NEUROTRANSMITTER UPTAKE; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; UPREGULATION;

ANIMALS; APOPTOSIS; BIOPTERIN; CASPASE 3; CELL COUNT; CELLS, CULTURED; COLORING AGENTS; CYTOCHROMES C; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHYSIOLOGY; GAMMA-AMINOBUTYRIC ACID; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MEMBRANE POTENTIALS; MESENCEPHALON; NEURONS; OXIDATIVE STRESS; PARKINSON DISEASE; RATS;

EID: 33751090747     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2006.08.024     Document Type: Article

References (56)

1. Alam Z.I., Daniel S.E., Lees A.J., Marsden D.C., Jenner P., and Halliwell B. A generalised increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease. J. Neurochem. 69 (1997) 1326-1329
2. Anastasiadis P.Z., Kuhn D.M., and Levine R.A. Tetrahydrobiopterin uptake into rat brain synaptosomes, cultured PC12 cells, and rat striatum. Brain Res. 665 (1994) 77-84
3. Anastasiadis P.Z., Jiang H., Bezin L., Kuhn D.M., and Levine R.A. Tetrahydrobiopterin enhances apoptotic PC12 cell death following withdrawal of trophic support. J. Biol. Chem. 276 (2001) 9050-9058
4. Anglade P., Vyas S., Javoy-Agid F., Herrero M.T., Michel P.P., Marquez J., Mouatt-Prigent A., Ruberg M., Hirsch E.C., and Agid Y. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histol. Histopathol. 12 (1997) 25-31
5. Berman S.B., and Hastings T.G. Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease. J. Neurochem. 73 (1999) 1127-1137
6. Brewer B.J. Serum-free B27/neurobasal medium supports differentiated growth of neurons from the striatum, substantia nigra, septum, cerebral cortex, cerebellum, and dentate gyrus. J. Neurosci. Res. 42 (1995) 674-683
7. Cheung N.S., Hickling Y.M., and Beart P.M. Development and survival of rat embryonic mesencephalic dopaminergic neurones in serum-free, antioxidant-rich primary cultures. Neurosci. Lett. 233 (1997) 13-16
8. Cho S., Volpe B.T., Bae Y., Hwang O., Choi H.J., Gal J., Park L.C., Chu C.K., Du J., and Joh T.H. Blockade of tetrahydrobiopterin synthesis protects neurons after transient forebrain ischemia in rat: a novel role for the cofactor. J. Neurosci. 19 (1999) 878-889
9. Choi H.J., Jang Y.J., Kim H.J., and Hwang O. Tetrahydrobiopterin is released from and causes preferential death of catecholaminergic cells by oxidative stress. Mol. Pharmacol. 58 (2000) 633-640
10. Choi H.J., Kim S.W., Lee S.Y., and Hwang O. Dopamine-dependent cytotoxicity of tetrahydrobiopterin: a possible mechanism for selective neurodegeneration in Parkinson's disease. J. Neurochem. 86 (2003) 143-152
11. Choi H.J., Kim S.W., Moon Y.W., and Hwang O. Involvement of apoptosis and calcium mobilization in tetrahydrobiopterin-induced dopaminergic cell death. Exp. Neurol. 181 (2003) 281-290
12. Choi H.J., Kim S.W., Im J.H., Lee S.G., Kim M., and Hwang O. Utilization of Exogenous tetrahydrobiopterin in nitric oxide synthesis in human neuroblastoma cell line. Neurosci. Lett. 352 (2003) 89-92
13. Choi J., Levey A.I., Weintraub S.T., Rees H.D., Gearing M., Chin L.S., and Li L. Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases. J. Biol. Chem. 279 (2004) 13256-13264
14. Choi H.J., Lee S.Y., Cho Y., and Hwang O. Inhibition of vesicular monoamine transporter enhances vulnerability of dopaminergic cells: relevance to Parkinson's disease. Neurochem. Int. 46 (2005) 329-335
15. Conway K.A., Rochet J.C., Bieganski R.M., and Lansbury Jr. P.T. Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct. Science 294 (2001) 1346-1349
16. Davies K.J. Degradation of oxidized proteins by the 20S proteasome. Biochimie 83 (2001) 301-310
17. Davis M.D., Kaufman S., and Milstien S. The auto-oxidation of tetrahydrobiopterin. Eur. J. Biochem. 173 (1988) 345-351
18. Dexter D.T., Carter C.J., Wells F.R., Javoy-Agid F., Agid Y., Lees A., Jenner P., and Marsden C.D. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J. Neurochem. 52 (1989) 381-389
19. Fisher D.B., and Kaufman S. Tetrahydropterin oxidation without hydroxylation catalyzed by rat liver phenylalanine hydroxylase. J. Biol. Chem. 248 (1973) 4300-4304
20. Floor E., and Wetzel M.G. Increased protein oxidation in human substantia nigra pars compacta in comparison with basal ganglia and prefrontal cortex measured with an improved dinitrophenylhydrazine assay. J. Neurochem. 70 (1998) 268-275
21. Friedlander R.M. Role of caspase 1 in neurologic disease. Arch. Neurol. 57 (2000) 1273-1276
22. Graham D.G., Tiffany S.M., Bell Jr. W.R., and Gutknecht W.F. Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro. Mol. Pharmacol. 14 (1978) 644-653
23. Hartmann A., Hunot S., Michel P.P., Muriel M.P., Vyas S., Faucheux B.A., Mouatt-Prigent A., Turmel H., Srinivasan A., Ruberg M., Evan G.I., Agid Y., and Hirsch E.C. Caspase-3: a vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 2875-2880
24. He Y., Thong P.S., Lee T., Leong S.K., Mao B.Y., Dong F., and Watt F. Dopaminergic cell death precedes iron elevation in MPTP-injected monkeys. Free Radical Biol. Med. 35 (2003) 540-547
25. Hirsch E., Graybiel A.M., and Agid Y.A. Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease. Nature 334 (1988) 345-348
26. Hwang O., Baker H., Gross S., and Joh T.H. Localization of GTP cyclohydrolase in monoaminergic but not nitric oxide-producing cells. Synapse 28 (1998) 140-153
27. Hwang O., Choi H.J., and Park S.Y. Up-regulation of GTP cyclohydrolase I and tetrahydrobiopterin by calcium influx. NeuroReport 10 (1999) 3611-3614
28. Kaufman S. New tetrahydrobiopterin-dependent systems. Annu. Rev. Nutr. 13 (1993) 261-286
29. Keller J.N., Huang F.F., Dimayuga E.R., and Maragos W.F. Dopamine induces proteasome inhibition in neural PC12 cell line. Free Radical Biol. Med. 29 (2000) 1037-1042
30. Kim W.G., Mohney R.P., Wilson B., Jeohn G.H., Liu B., and Hong J.S. Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia. J. Neurosci. 20 (2000) 6309-6316
31. Kim S.W., Jang Y.J., Chang J.W., and Hwang O. Degeneration of the nigrostriatal pathway and induction of motor deficit by tetrahydrobiopterin: an in vivo model relevant to Parkinson's disease. Neurobiol. Dis. 13 (2003) 167-176
32. Kim S.T., Chang J.W., Hong H.N., and Hwang O. Loss of striatal dopaminergic fibers after intraventricular injection of tetrahydrobiopterin in rat brain. Neurosci. Lett. 359 (2004) 69-72
33. Kim S.T., Chang J.W., Choi J.H., Kim S.W., and Hwang O. Immobilization stress causes increases in tetrahydrobiopterin, dopamine, and neuromelanin and oxidative damage in the nigrostriatal system. J. Neurochem. 95 (2005) 89-98
34. Kim Y.S., Kim S.S., Cho J.J., Choi D.H., Hwang O., Shin D.H., Chun H.S., Beal M.F., and Joh T.H. Matrix metalloproteinase-3: a novel signaling proteinase from apoptotic neuronal cells that activates microglia. J. Neurosci. 25 (2005) 3701-3711
35. Kirsch M., Korth H.G., Stenert V., Sustmann R., and de Groot H. The autoxidation of tetrahydrobiopterin revisited. Proof of superoxide formation from reaction of tetrahydrobiopterin with molecular oxygen. J. Biol. Chem. 278 (2003) 24481-24490
36. Kuhn D.M., Arthur Jr. R.E., Thomas D.M., and Elferink L.A. Tyrosine hydroxylase is inactivated by catechol-quinones and converted to a redox-cycling quinoprotein: possible relevance to Parkinson's disease. J. Neurochem. 73 (1999) 1309-1317
37. Kwon N.S., Nathan C.F., and Stuehr D.J. Reduced biopterin as a cofactor in the generation of nitrogen oxides by murine macrophages. J. Biol. Chem. 264 (1989) 20496-20501
38. LaVoie M.J., and Hastings T.G. Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine. J. Neurosci. 19 (1999) 1484-1491
39. Lee C.S., Han J.H., Jang Y.Y., Song J.H., and Han E.S. Differential effect of catecholamines and MPP(+) on membrane permeability in brain mitochondria and cell viability in PC12 cells. Neurochem. Int. 40 (2002) 361-369
40. Madsen J.T., Jansen P., Hesslinger C., Meyer M., Zimmer J., and Gramsbergen J.B. Tetrahydrobiopterin precursor sepiapterin provides protection against neurotoxicity of 1-methyl-4-phenylpyridinium in nigral slice cultures. J. Neurochem. 85 (2003) 214-223
41. Mochizuki H., Goto K., Mori H., and Mizuno Y. Histochemical detection of apoptosis in Parkinson's disease. J. Neurol. Sci. 137 (1996) 120-123
42. Mogi M., Togari A., Kondo T., Mizuno Y., Komure O., Kuno S., Ichinose H., and Nagatsu T. Caspase activities and tumor necrosis factor receptor R1 (p55) level are elevated in the substantia nigra from parkinsonian brain. J. Neural Transm. 107 (2000) 335-341
43. Moore D.J., West A.B., Dawson V.L., and Dawson T.M. Molecular pathophysiology of Parkinson's disease. Annu. Rev. Neurosci. 28 (2005) 57-87
44. Nagatsu I., Ichinose H., Sakai M., Titani K., Suzuki M., and Nagatsu T. Immunocytochemical localization of GTP cyclohydrolase I in the brain, adrenal gland, and liver of mice. J. Neural Transm. Gen. Sect. 102 (1995) 175-188
45. Nakamura K., Wright D.A., Wiatr T., Kowlessur D., Milstien S., Lei X.G., and Kang U.J. Preferential resistance of dopaminergic neurons to the toxicity of glutathione depletion is independent of cellular glutathione peroxidase and is mediated by tetrahydrobiopterin. J. Neurochem. 74 (2000) 2305-2314
46. Nakamura K., Bindokas V.P., Kowlessur D., Elas M., Milstien S., Marks J.D., Halpern H.J., and Kang U.J. Tetrahydrobiopterin scavenges superoxide in dopaminergic neurons. J. Biol. Chem. 276 (2001) 34402-34407
47. Obata T. Dopamine efflux by MPTP and hydroxyl radical generation. J. Neural Transm. 109 (2002) 1159-1180
48. Oettl K., and Reibnegger G. Pteridine derivatives as modulators of oxidative stress. Curr. Drug Metab. 3 (2002) 203-209
49. Sian J., Dexter D.T., Lees A.J., Daniel S., Agid Y., Javoy-Agid F., Jenner P., and Marsden C.D. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann. Neurol. 36 (1994) 348-355
50. Sofic E., Lange K.W., Jellinger K., and Riederer P. Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease. Neurosci. Lett. 142 (1992) 128-130
51. Teismann P., and Schulz J.B. Cellular pathology of Parkinson's disease: astrocytes, microglia and inflammation. Cell Tissue Res. 318 (2004) 149-161
52. Thoeni G., Werner E.R., and Werner-Felmayer G. Tetrahydropteridines suppress gene expression and induce apoptosis of activated RAW264.7 cells via formation of hydrogen peroxide. Free Radical Biol. Med. 37 (2004) 375-385
53. Velasco I., Salazar M.A., Lajud P., and Tapia N. Influence of serum-free medium on the expression of glutamate transporters and the susceptibility to glutamate toxicity in cultured cortical neurons. J. Neurosci. Res. 71 (2003) 811-818
54. Wilms H., Rosenstiel P., Sievers J., Deuschl G., Zecca L., and Lucius R. Activation of microglia by human neuromelanin is NF-kappaB dependent and involves p38 mitogen-activated protein kinase: implications for Parkinson's disease. FASEB J. 17 (2003) 500-502
55. Wong A., and Cortopassi G.S. High-throughput measurement of mitochondrial membrane potential in a neural cell line using a fluorescence plate reader. Biochem. Biophys. Res. Commun. 298 (2002) 750-754
56. Zhang W., Wang T., Pei Z., Mille D.S., Wu X., Block M.L., Wilson B., Zhang W., Zhou Y., Hong J.S., and Zhang J. Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease. FASEB J. 19 (2005) 533-542